Recent Finacing
Recent Raise
Nucleix develops and markets non-invasive molecular cancer diagnostics using EpiCheck to detect DNA methylation, employing NGS for discovery and PCR assays such as Bladder EpiCheck and Lung EpiCheck.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
